tirzepatide injection site itchy & Zepbound Rash and Injection-Site Reactions: Causes, Treatment, and Prevention Injection Site Reactions Increasing :

Yki-Jrvinen H, Bergenstal R, Ziemen M et al (2014) New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2)

GLP-1 drugs research timeline Weight loss drugs show promise for treating alcohol addiction Weight loss drugs effective but confer no benefit to quality of life GLP-1 drugs linked to lower long-term risk of knee replacement Appetite suppressant drugs show promise for treating addiction Stopping weight loss jabs leads to faster weight regain than after diets Drug found to be effective at treating early-onset type 2 diabetes Weight loss drug could ward off diabetes in at-risk patients

thyroid cancer history warrants caution (animal studies showed thyroid tumors, though this hasnt translated to human risk at approved doses)

[DOI] [PubMed] [Google Scholar] 101.Mitchell J.L., Lyons H.S., Walker J.K., Yiangou A., Grech O., Alimajstorovic Z., Greig N.H., Li Y., Tsermoulas G., Brock K., et al